<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00121524</url>
  </required_header>
  <id_info>
    <org_study_id>525-02201</org_study_id>
    <nct_id>NCT00121524</nct_id>
  </id_info>
  <brief_title>Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome</brief_title>
  <official_title>Effects of Epinephrine and I.V. Needle on CPR Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Petter Andreas Steen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laerdal Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Region East, Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Air Ambulance Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oslo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation
      since the start. It improves outcome in animal studies, but has never been investigated in a
      controlled study in humans. Epidemiologic data indicate that it is an independent negative
      predictor for survival. If this is true in a controlled randomized study, it could be due to
      effects of the drug itself or more likely due to reduced quality of chest compressions and
      ventilations due to the time spent on placing an I.V. needle and injecting drugs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a randomized, controlled study of all out-of-hospital cardiac arrest patients in Oslo,
      Norway, half the patients are treated according to the international guidelines for advanced
      CPR, and the other half according to the same guidelines, except for no I.V. needle or drugs
      are given until 5 minutes after eventual return of spontaneous circulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>survival to hospital discharge with neurologic outcome</measure>
    <time_frame>discharge from hospital</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>admit to hospital with spontaneous circulation</measure>
    <time_frame>hospital admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>one year survival with neurologic outcome</measure>
    <time_frame>one year after hospital discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">904</enrollment>
  <condition>Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>IV yes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous needle Epinephrine q 3 min during CPR Atropine 3 mg in initial asystole Amiodarone 300 mg iv after repeated failed defibrillation attempts</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV no</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patient will not have an intravenous needle placed or given any drugs during CPR. If patient obtains spontaneous circulation, an intravenous needle is placed and patient can receive any drugs that are appropriate during the following treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Epinephrine 1 mg is given iv. every 3 min during CPR</description>
    <arm_group_label>IV yes</arm_group_label>
    <other_name>Adrenaline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intravenous needle</intervention_name>
    <description>An intravenous needle in placed as soon as possible during CPR</description>
    <arm_group_label>IV yes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atropine</intervention_name>
    <description>Atropine 3 mg iv in initial systole</description>
    <arm_group_label>IV yes</arm_group_label>
    <other_name>Atropine sulfate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amiodarone</intervention_name>
    <description>amiodarone 300 mg iv after repeated failed defibrillation attempts</description>
    <arm_group_label>IV yes</arm_group_label>
    <other_name>Amiodaron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac arrest out-of-hospital

        Exclusion Criteria:

          -  &lt;18 years old

          -  Trauma as cause of arrest
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Wik, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ulleval University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>N-0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Holmberg M, Holmberg S, Herlitz J. Low chance of survival among patients requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac arrest in Sweden. Resuscitation. 2002 Jul;54(1):37-45.</citation>
    <PMID>12104107</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2005</study_first_submitted>
  <study_first_submitted_qc>July 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2005</study_first_posted>
  <last_update_submitted>May 28, 2015</last_update_submitted>
  <last_update_submitted_qc>May 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Oslo</investigator_affiliation>
    <investigator_full_name>Petter Andreas Steen</investigator_full_name>
    <investigator_title>Professor Acute Medicine</investigator_title>
  </responsible_party>
  <keyword>cardiac arrest</keyword>
  <keyword>resuscitation</keyword>
  <keyword>epinephrine</keyword>
  <keyword>intravenous</keyword>
  <keyword>survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Amiodarone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

